Tokyo, Oct. 6 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063177) titled 'Study of Ki67 assessment practices and patient characteristics in hormone receptor-positive, HER2-negative early breast cancer' on Oct. 5.
Study Type:
Observational
Primary Sponsor:
Institute - Showa Medical University
Condition:
Condition - Hormone receptor-positive, HER2-negative early breast cancer
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To describe real-world Ki67 assessment practices for HR-positive, HER2-negative early breast cancer in Japan and retrospectively characterize patient factors associated with recurrence risk using medical records.
Bas...